DB Biotech Inc., Kosice, Slovakia, EU is focused on the design and production of high quality rabbit clonal antibodies developed by a novel and proprietary in-vitro cloning technology which has been developed and perfected by the DBB scientific team over a period of 20 years. DB Biotech monospecific clonal antibodies are uniquely characterized by exceptional specificity, affinity and avidity.
The DB Biotech in-vitro cloning technology enables the preparation of a pure immunoglobulin fraction corresponding to a single clone of B lymphocytes. The obtained immunoglobulin recognizes only one single linear epitope on the antigen molecule, making a DB Biotech antibody comparable in quality to its monoclonal analogue.
In addition, the influence of the protein tertiary structure – frequently present in epitopes formed during production of monoclonal antibodies – is eliminated in the immunoglobulins corresponding to the clonal antibody. DB Biotech produced antibodies correspond strictly to the conserved linear epitope of the antigen molecule, yielding a higher-quality, more specific antibody with significantly better affinity and avidity.
Founded in 2006
for business please contact
Sales
sales@dbbiotech.com or dbbiotech@dbbiotech.com
Company Details
- Employees
- 9
- Founded
- -
- Address
- Popradská 80, Košice,košický Kraj 040 11,slovakia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- dbbiotech.com
- HQ
- Košice, Košický kraj
- Competitors
- T&D Diagnostics Canada, AECFUL, BB Biotech.
Db Biotech Questions
Db Biotech's website is dbbiotech.com
Db Biotech's LinkedIn profile is https://sk.linkedin.com/company/db-biotech
Db Biotech has
9 employees.
View email and phone details for 9
employees at Db Biotech.
Db Biotech's industry is
Biotechnology Research
Db Biotech's categories are Biotechnology Research
Db Biotech's founding year is 2006
